FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W1861356471> ?p ?o ?g. }

• W1861356471 endingPage "319" @default.
• W1861356471 startingPage "311" @default.
• W1861356471 abstract "After treatment for localized prostate cancer, many survivors experience severe physical and psychological/psychosocial impairments, such as urinary incontinence, erectile dysfunction, fatigue, depressive symptoms and decreased physical functioning. Physical activity and exercise can positively influence such side effects and improve quality of life. However, the majority of prostate cancer survivors are not physically active. Thus, supportive interventions, such as supervised exercise programs, are necessary. But particularly in the post-treatment phase, infrastructure and resources are limited and specific exercise recommendations for prostate cancer survivors do not yet exist.The ProCaLife study is a quasi-randomized controlled intervention trial evaluating a specific 26-week physical exercise program for prostate cancer survivors in the rehabilitation phase following medical treatment. Participants are assigned to one of two intervention groups (supervised multi-modal physical exercise including or not including further behavior-oriented techniques) or a control group (not receiving any supervised intervention). Exercise sessions are performed twice weekly and contain specific aerobic, strengthening, flexibility, balance, relaxation and pelvic floor/sphincter exercises as well as mixed games. Behavior-oriented techniques include physical activity-related knowledge transfer and barriers management. The primary endpoint quality of life and secondary psychological/psychosocial, urological, physical fitness and physical activity outcomes are assessed at pre-intervention, post-intervention and follow-up time points.By evaluating a specific supervised multi-modal physical exercise program, the ProCaLife study contributes to identify effective forms of physical exercise for prostate cancer survivors in the rehabilitation phase. This is of great importance for establishing specific exercise recommendations which are missing so far." @default.
• W1861356471 created "2016-06-24" @default.
• W1861356471 creator A5009601378 @default.
• W1861356471 creator A5018835914 @default.
• W1861356471 creator A5028937620 @default.
• W1861356471 creator A5032655236 @default.
• W1861356471 creator A5034248255 @default.
• W1861356471 creator A5044602949 @default.
• W1861356471 date "2015-11-01" @default.
• W1861356471 modified "2023-10-10" @default.
• W1861356471 title "Evaluation of a supervised multi-modal physical exercise program for prostate cancer survivors in the rehabilitation phase: Rationale and study protocol of the ProCaLife study" @default.
• W1861356471 cites W1518728900 @default.
• W1861356471 cites W1524830325 @default.
• W1861356471 cites W1534055097 @default.
• W1861356471 cites W1560595865 @default.
• W1861356471 cites W1646225421 @default.
• W1861356471 cites W1950009931 @default.
• W1861356471 cites W1965023308 @default.
• W1861356471 cites W1967470185 @default.
• W1861356471 cites W1968400906 @default.
• W1861356471 cites W1969298178 @default.
• W1861356471 cites W1969862162 @default.
• W1861356471 cites W1976004349 @default.
• W1861356471 cites W1976360003 @default.
• W1861356471 cites W1978328234 @default.
• W1861356471 cites W1985044219 @default.
• W1861356471 cites W1990849299 @default.
• W1861356471 cites W1995358795 @default.
• W1861356471 cites W1997807525 @default.
• W1861356471 cites W2000696254 @default.
• W1861356471 cites W2003239266 @default.
• W1861356471 cites W2004008756 @default.
• W1861356471 cites W2006497677 @default.
• W1861356471 cites W2009044819 @default.
• W1861356471 cites W2010507806 @default.
• W1861356471 cites W2011391403 @default.
• W1861356471 cites W2013338689 @default.
• W1861356471 cites W2017197202 @default.
• W1861356471 cites W2017973963 @default.
• W1861356471 cites W2019136566 @default.
• W1861356471 cites W2019740701 @default.
• W1861356471 cites W2021604300 @default.
• W1861356471 cites W2025298047 @default.
• W1861356471 cites W2026641917 @default.
• W1861356471 cites W2033380798 @default.
• W1861356471 cites W2034757894 @default.
• W1861356471 cites W2039406287 @default.
• W1861356471 cites W2040008722 @default.
• W1861356471 cites W2042665630 @default.
• W1861356471 cites W2042798052 @default.
• W1861356471 cites W2056524616 @default.
• W1861356471 cites W2060139124 @default.
• W1861356471 cites W2064485164 @default.
• W1861356471 cites W2066028007 @default.
• W1861356471 cites W2069556801 @default.
• W1861356471 cites W2078664117 @default.
• W1861356471 cites W2086240335 @default.
• W1861356471 cites W2096260602 @default.
• W1861356471 cites W2097146819 @default.
• W1861356471 cites W2103607521 @default.
• W1861356471 cites W2106011651 @default.
• W1861356471 cites W2107601840 @default.
• W1861356471 cites W2110521171 @default.
• W1861356471 cites W2112395080 @default.
• W1861356471 cites W2125668498 @default.
• W1861356471 cites W2129820993 @default.
• W1861356471 cites W2129951557 @default.
• W1861356471 cites W2135528979 @default.
• W1861356471 cites W2137383164 @default.
• W1861356471 cites W2137880005 @default.
• W1861356471 cites W2142912849 @default.
• W1861356471 cites W2145139856 @default.
• W1861356471 cites W2147312821 @default.
• W1861356471 cites W2148566224 @default.
• W1861356471 cites W2152937519 @default.
• W1861356471 cites W2159611666 @default.
• W1861356471 cites W2160612556 @default.
• W1861356471 cites W2160619944 @default.
• W1861356471 cites W2160769891 @default.
• W1861356471 cites W2161431826 @default.
• W1861356471 cites W2162812015 @default.
• W1861356471 cites W2163524004 @default.
• W1861356471 cites W2164221643 @default.
• W1861356471 cites W2166281097 @default.
• W1861356471 cites W2167571044 @default.
• W1861356471 cites W2169434152 @default.
• W1861356471 cites W2169961966 @default.
• W1861356471 cites W2213289322 @default.
• W1861356471 cites W2316817608 @default.
• W1861356471 cites W2327362588 @default.
• W1861356471 cites W2331198201 @default.
• W1861356471 cites W2401530912 @default.
• W1861356471 cites W2599228863 @default.
• W1861356471 cites W2915478882 @default.
• W1861356471 cites W587273905 @default.
• W1861356471 cites W615572723 @default.
• W1861356471 doi "https://doi.org/10.1016/j.cct.2015.09.020" @default.
• W1861356471 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/26427561" @default.

• next